Back to Search
Start Over
Cannabinoid CB1 and CB2 receptors differentially modulate L- and T-type Ca 2+ channels in rat retinal ganglion cells.
- Source :
-
Neuropharmacology [Neuropharmacology] 2017 Sep 15; Vol. 124, pp. 143-156. Date of Electronic Publication: 2017 Apr 18. - Publication Year :
- 2017
-
Abstract
- Endocannabinoid signaling system is involved in regulating multiple neuronal functions in the central nervous system by activating G-protein coupled cannabinoid CB1 and CB2 receptors (CB1Rs and CB2Rs). Growing evidence has shown that CB1Rs and CB2Rs are extensively expressed in retinal ganglion cells (RGCs). Here, modulation of L- and T-types Ca <superscript>2+</superscript> channels by activating CB1Rs and CB2Rs in RGCs was investigated. Triple immunofluorescent staining showed that L-type subunit Ca <subscript>V</subscript> 1.2 was co-localized with T-type subunits (Ca <subscript>V</subscript> 3.1, Ca <subscript>V</subscript> 3.2 and Ca <subscript>V</subscript> 3.3) in rat RGCs. In acutely isolated rat RGCs, the CB1R agonist WIN55212-2 suppressed both peak and steady-state Ca <superscript>2+</superscript> currents in a dose-dependent manner, with IC <subscript>50</subscript> being 9.6 μM and 8.4 μM, respectively. It was further shown that activation of CB1Rs by WIN55212-2 or ACEA, another CB1R agonist, significantly suppressed both L- and T-type Ca <superscript>2+</superscript> currents, and shifted inactivation curve of T-type one toward hyperpolarization direction. While the effect on L-type Ca <superscript>2+</superscript> channels was mediated by intracellular cAMP/protein kinase A (PKA), mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) and calcium/calmodulin-dependent protein kinase II (CaMKII) signaling pathways, only CaMKII signaling pathway was involved in the effect on T-type Ca <superscript>2+</superscript> channels. Furthermore, CB65 and HU308, two specific CB2R agonists, significantly suppressed T-type Ca <superscript>2+</superscript> channels, which was mediated by intracellular cAMP/PKA and CaMKII signaling pathways, but had no effect on L-type channels. These results imply that endogenous cannabinoids may modulate the excitability and the output of RGCs by differentially suppressing the activity of L- and T-type Ca <superscript>2+</superscript> channels through activation of CB1Rs and CB2Rs. This article is part of the Special Issue entitled "A New Dawn in Cannabinoid Neurobiology".<br /> (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Arachidonic Acids pharmacology
Benzoxazines pharmacology
Cannabinoids pharmacology
Dose-Response Relationship, Drug
Male
Membrane Potentials drug effects
Naphthalenes pharmacology
Rats
Receptor, Cannabinoid, CB1 agonists
Receptor, Cannabinoid, CB2 agonists
Signal Transduction physiology
Calcium Channels, L-Type physiology
Calcium Channels, T-Type physiology
Cyclohexanes pharmacology
Morpholines pharmacology
Quinolines pharmacology
Receptor, Cannabinoid, CB1 physiology
Receptor, Cannabinoid, CB2 physiology
Retinal Ganglion Cells physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7064
- Volume :
- 124
- Database :
- MEDLINE
- Journal :
- Neuropharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 28431968
- Full Text :
- https://doi.org/10.1016/j.neuropharm.2017.04.027